Characteristic | Control group(n = 903) | IS group (n = 1078) | P value | |
 Age(years) | 57.0 ± 14.9 | 64.4 ± 12.3 | 0.486 | |
 Sex(male%) | 474(52.5) | 677(62.8) | <  10− 3 | |
 Hypertension (%) | 154(17.1) | 729(67.6) | <  10− 3 | |
 Diabetes (%) | 59(6.5) | 361(33.5) | <  10−3 | |
 Hyperlipidemia (%) | 90(10.0) | 177(16.4) | <  10−3 | |
 Coronary heart disease (%) | 10(1.1) | 115(10.7) | <  10−3 | |
 Smoking (%) | 244(27.0) | 369 (34.2) | 0.001 | |
 Alcohol consumption(%) | 175(19.6) | 235(21.9) | 0.214 | |
 TG(mmol/L) | 1.50 ± 1.13 | 2.27 ± 24.2 | 0.342 | |
 TC(mmol/L) | 4.36 ± 1.03 | 4.27 ± 2.73 | 0.311 | |
 HDL-C(mmol/L) | 1.36 ± 0.43 | 1.25 ± 0.50 | <  10−3 | |
 LDL-C(mmol/L) | 2.73 ± 7.05 | 2.47 ± 0.96 | 0.230 | |
 Fibrinogen levels (mmol/L) | 2.20 ± 1.59 | 3.16 ± 1.00 | <  10−3 | |
 Plt(10^9/L) | 178.5 ± 72.1 | 169.0 ± 66.70 | 0.021 | |
Characteristic | LAA group (n = 405) | CES group(n = 136) | SVO group(n = 537) | P value |
 Age(years) | 63.2 ± 12.6 | 64.5 ± 12.9 | 64.9 ± 11.9 | 0.079 |
 Sex(male%) | 274(67.7) | 62(45.6) | 341(63.5) | <  10−3 |
 Hypertension (%) | 268(66.2) | 65(47.8) | 396(67.6) | <  10−3 |
 Diabetes (%) | 132(32.6) | 24(17.6) | 205(38.2) | <  10−3 |
 Hyperlipidemia (%) | 68(16.8) | 13(9.6) | 96(17.9) | 0.063 |
 Coronary heart disease (%) | 45(11.1) | 18(13.2) | 52(9.7) | 0.457 |
 Smoking (%) | 162(40.0) | 25(18.4) | 182(33.9) | <  10−3 |
 Alcohol consumption(%) | 102 (25.2) | 17(12.6) | 116(21.7) | 0.009 |
 TG(mmol/L) | 1.65 ± 1.22 | 1.26 ± 0.66 | 2.52 ± 27.79 | 0.042 |
 TC(mmol/L) | 4.51 ± 4.88 | 4.00 ± 1.58 | 4.21 ± 1.15 | 0.367 |
 HDL-C(mmol/L) | 1.24 ± 0.68 | 1.30 ± 0.43 | 1.24 ± 0.40 | 0.926 |
 LDL-C(mmol/L) | 2.44 ± 0.94 | 2.64 ± 3.87 | 2.49 ± 0.99 | 0.084 |
 Fibrinogen levels (mmol/L) | 3.22 ± 0.97 | 2.98 ± 1.04 | 3.16 ± 1.00 | 0.012 |
 Plt(10^9/L) | 171.2 ± 63.5 | 151.5 ± 61.0 | 171.0 ± 67.2 | 0.003 |